BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32346744)

  • 21. Neoadjuvant-Intent Immunotherapy in Advanced, Resectable Cutaneous Squamous Cell Carcinoma.
    Kim EY; Ruiz ES; DeSimone MS; Shalhout SZ; Hanna GJ; Miller DM; Schmults C; Rettig EM; Foreman RK; Sethi R; Thakuria M; Silk AW
    JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):414-420. PubMed ID: 38546619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines of care for the management of cutaneous squamous cell carcinoma.
    ; ; Kim JYS; Kozlow JH; Mittal B; Moyer J; Olenecki T; Rodgers P
    J Am Acad Dermatol; 2018 Mar; 78(3):560-578. PubMed ID: 29331386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term survival after anti-PD-1 discontinuation in advanced cutaneous squamous cell carcinoma (cSCC): a proof of concept of benefit of concomitant cemiplimab and radiotherapy.
    Bailly-Caillé B; Levard R; Kottler D; Dompmartin A; L'Orphelin JM
    Cancer Immunol Immunother; 2024 May; 73(7):118. PubMed ID: 38713217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma.
    Migden MR; Chandra S; Rabinowits G; Chen CI; Desai J; Seluzhytsky A; Sasane M; Campanelli B; Chen Z; Freeman ML; Ibrahim SF; Khushalani NI; Andria M; Ruiz E
    Future Oncol; 2020 Feb; 16(4):11-19. PubMed ID: 31951149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-risk cutaneous squamous cell carcinoma.
    Nuño-González A; Vicente-Martín FJ; Pinedo-Moraleda F; López-Estebaranz JL
    Actas Dermosifiliogr; 2012 Sep; 103(7):567-78. PubMed ID: 22261673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma.
    Ascierto PA; Schadendorf D
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36455990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
    Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
    J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beyond the dermis-high-risk invasive squamous cell carcinoma: a retrospective review.
    Sood A; Bivona L; Mahkzoumi Z; Hausner P; Miller K; Regine WF; Snider J; Ng VY
    J Wound Care; 2020 Oct; 29(10):556-561. PubMed ID: 33052788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early and Severe Radiation Toxicity Associated with Concurrent Sirolimus in an Organ Transplant Recipient with Head and Neck Cutaneous Squamous Cell Carcinoma: A Case Report.
    Manyam BV; Nwizu TI; Rahe ML; Harr BA; Koyfman SA
    Anticancer Res; 2015 Oct; 35(10):5511-4. PubMed ID: 26408717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
    Eggermont AM
    Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
    Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Fargnoli MC; Forsea AM; Frenard C; Harwood CΑ; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
    Eur J Cancer; 2020 Mar; 128():60-82. PubMed ID: 32113941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cemiplimab for locally advanced cutaneous squamous cell carcinoma: safety, efficacy, and position in therapy panel.
    Lebas E; Marchal N; Rorive A; Nikkels AF
    Expert Rev Anticancer Ther; 2021 Apr; 21(4):355-363. PubMed ID: 33554680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of High-Risk Squamous Cell Carcinoma of the Skin.
    Fu T; Aasi SZ; Hollmig ST
    Curr Treat Options Oncol; 2016 Jul; 17(7):34. PubMed ID: 27262708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous squamous cell carcinoma metastatic to the axilla and groin: Outcomes and prognostic factors.
    Bucknell NW; Gyorki DE; Bressel M; Estall V; Webb A; Henderson M; Chua MS; Rischin D; Tiong A
    Australas J Dermatol; 2022 Feb; 63(1):43-52. PubMed ID: 34751431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of selected risk factors for nodal metastases in head and neck cutaneous squamous cell carcinoma.
    Szewczyk M; Pazdrowski J; Golusiński P; Dańczak-Pazdrowska A; Marszałek S; Golusiński W
    Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):3007-12. PubMed ID: 25217080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Total Parotidectomy for Metastatic Cutaneous Squamous Cell Carcinoma and Malignant Melanoma.
    Thom JJ; Moore EJ; Price DL; Kasperbauer JL; Starkman SJ; Olsen KD
    JAMA Otolaryngol Head Neck Surg; 2014 Jun; 140(6):548-54. PubMed ID: 24722863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Covering of parotid and cervical lymph nodes metastasis of cutaneous squamous cell carcinoma of the head, about 18 cases].
    Vatin L; Morvan JB; Rivière D; Okremchouk I; Abed S; Verdalle P
    Rev Laryngol Otol Rhinol (Bord); 2015; 136(1):9-15. PubMed ID: 26749599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of High-Risk Subgroups of Patients With Oral Cavity Cancer in Need of Postoperative Adjuvant Radiotherapy or Chemo-Radiotherapy.
    Chen WC; Lai CH; Fang CC; Yang YH; Chen PC; Lee CP; Chen MF
    Medicine (Baltimore); 2016 May; 95(22):e3770. PubMed ID: 27258508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update of advanced cutaneous squamous cell carcinoma.
    de Jong E; Lammerts MUPA; Genders RE; Bouwes Bavinck JN
    J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1(Suppl 1):6-10. PubMed ID: 34855246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes.
    Horenblas S; van Tinteren H; Delemarre JF; Moonen LM; Lustig V; van Waardenburg EW
    J Urol; 1993 Mar; 149(3):492-7. PubMed ID: 8437253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.